GlassScriptPhysician profile
Lauren E Bourgeois
NPI 1720753940
$1,393.51
in general payments reported to CMS, 2019-2025
14 companies · $94.60 in 2025
The $94.60 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $87.75 · 2022: $518 · 2023: $391 · 2024: $303 · 2025: $94.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $787.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $245.10 | 2021-2024 | Yupelri |
| Astrazeneca Pharmaceuticals LP | $191.32 | 2022-2024 | Fasenra, Tezspire |
| Glaxosmithkline, LLC. | $186.70 | 2022-2024 | Trelegy Ellipta, Arexvy, Nucala |
| Bayer Healthcare Pharmaceuticals INC. | $167.11 | 2021-2023 | |
| Genzyme Corporation | $154.07 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $143.36 | 2022-2024 | Dupixent |
| Baxter Healthcare | $102.83 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.91 | 2022-2024 | Ofev |
| Insmed, INC. | $36.19 | 2022-2023 | Arikayce |
| Lundbeck LLC | $26.59 | 2024 | Vyepti |
| Janssen Biotech, INC. | $24.19 | 2024 | Carvykti |
| Sobi, INC | $22.70 | 2025 | |
| Biomerieux INC | $22.29 | 2021 | |
| Eisai INC. | $22.15 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Bourgeois listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.